Selbyville, Delaware, June 02, 2021 (GLOBE NEWSWIRE) -- Seasoned analysts cite that global mRNA vaccine and therapeutics market size is projected to grow significantly between 2021-2030 to be appraised at USD 29672.31 million in 2025. Application of mRNA in cancer therapies and development of the Covid-19 vaccine are key factors credited for this growth. Rising number of cancer patients coupled with standardization of its treatment will also aid industry expansion.
Statistical data such as market size & valuation, production & consumption volume, and growth rate estimates are incorporated in the report. Furthermore, it examines the marketplace extensively by bifurcating it based on product gamut, end user spectrum, and region. Also, Covid-19 impact on business landscape is also elucidated.
The research literature provides in-depth profiling of leading companies, their investments portfolio, profit margins, market position, and product catalogue. Production capacity, industry share, and regional foothold for each company are given as well.
Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/3855667/
For the unversed, mRNA vaccine and therapeutics require less money to produce as compared to traditional medicines and offer higher effectiveness and enhanced immunogenicity. They are developed with the help of advanced technologies, having more efficacy against pathogens.
Increasing incidences of infectious ailments such as HIV and chronic diseases like cancer, cardiovascular disorders, and diabetes will also facilitate industry proliferation. Moreover, surging demand for vaccines for influenza, Ebola, HIV, and other viral illnesses, coupled with the inability of conventional methods to find vaccines on time will spur market growth.
Market segmentation overview:
Based on product gamut, global mRNA vaccine and therapeutics market is bifurcated into infectious disease vaccines, cancer vaccines, Covid-19 vaccines, autoimmune diseases, and others. Among these, the covid-19 vaccines segment is anticipated to hold a significant industry share by the end of forecast period.
Meanwhile, the industry space is divided into hospitals & clinics, research & organizations, and others when speaking of end-user gamut.
Regional fragmentation analysis:
As per expert verbatim, North America held majority of the worldwide mRNA vaccine and therapeutics market share for non-covid-19 vaccines in the recent past, owing to growing fund infusions, favorable regulations by government, and increasing focus to develop transformative therapeutics. Emphasis on establishing precision medicine will also contribute to this growth.
To access a sample copy or view this report in detail along with the table of contents, please click the link below:
Competitive landscape review:
Key players shaping global mRNA vaccine and therapeutics market dynamics are Pfizer Inc., Bayer AG, GlaxoSmithKline plc, AstraZeneca plc, Intellia Therapeutics, Sangamo Therapeutics Inc., Moderna Inc., BioNTech SE, C.H. Boehringer Sohn AG & Co. KG, and CRISPR Therapeutics AG.
Global mRNA Vaccine and Therapeutics Market by Product (Revenue, USD Million, 2015-2030)
- Infectious Disease Vaccines
- Cancer Vaccines
- Covid-19 Vaccines
- Autoimmune Diseases
- Others
Global mRNA Vaccine and Therapeutics Market by End User (Revenue, USD Million, 2015-2030)
- Research & Organizations
- Hospitals & Clinics
- Others
Global mRNA Vaccine and Therapeutics Market by Region (Revenue, USD Million, 2015-2030)
North America
- Canada
- U.S.
Europe
- Germany
- France
- U.K.
- Switzerland
- Russia
Asia Pacific
- India
- China
- Japan
Global mRNA Vaccine and Therapeutics Market Competitive Dashboard (Revenue, USD Million, 2015-2030)
- Pfizer Inc.
- Bayer AG
- GlaxoSmithKline plc
- AstraZeneca plc
- Intellia Therapeutics
- Sangamo Therapeutics Inc.
- Moderna Inc.
- BioNTech SE
- C.H. Boehringer Sohn AG & Co. KG
- CRISPR Therapeutics AG
Table of Content:
1. Report Scope and Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2.Strategic Recommendations
3. mRNA Vaccine and Therapeutics Market: Product Outlook
4. Global mRNA Vaccine and Therapeutics Market: Sizing and Forecast
4.1 Global mRNA Vaccine and Therapeutics Market Size, By Value, Year 2021-2030
5.Global mRNA Vaccine and Therapeutics Market Segmentation - By Product, By End User
5.1 Competitive Scenario of Global mRNA Vaccine and Therapeutics Market: By Product
5.1.1 COVID Vaccines - Market Size and Forecast (2021-2030)
5.1.2 Infectious Disease Vaccines - Market Size and Forecast (2021-2030)
5.1.3 Cancer Vaccines - Market Size and Forecast (2021-2030)
5.1.4 Autoimmune Diseases - Market Size and Forecast (2021-2030)
5.1.5 Others - Market Size and Forecast (2021-2030)
5.2 Competitive Scenario of Global mRNA Vaccine and Therapeutics Market: By End User
5.2.1 Hospitals & Clinics - Market Size and Forecast (2021-2030)
5.2.2 Research & Organizations - Market Size and Forecast (2021-2030)
5.2.3 Others - Market Size and Forecast (2021-2030)
6. Global mRNA Vaccine and Therapeutics Market: Regional Analysis
6.1 Competitive Scenario of Global mRNA Vaccine and Therapeutics Market: By Region
7.North America mRNA Vaccine and Therapeutics Market : An Analysis (2021-2030)
7.1 North America mRNA Vaccine and Therapeutics Market : Size and Forecast (2021-2030), By Value
7.2 North America mRNA Vaccine and Therapeutics Market - Prominent Companies
7.3 Market Segmentation By Product (COVID Vaccines, Infectious Disease Vaccines, Cancer Vaccines, Autoimmune Diseases, Others)
7.4 Market Segmentation End User (Hospitals & Clinics, Research & Organizations, Others)
7.5 North America mRNA Vaccine and Therapeutics Market: Country Analysis
8. Europe mRNA Vaccine and Therapeutics Market: An Analysis (2021-2030)
8.1 Europe mRNA Vaccine and Therapeutics Market: Size and Forecast (2021-2030), By Value
8.2 Europe mRNA Vaccine and Therapeutics Market - Prominent Companies
8.3 Market Segmentation By Product (COVID Vaccines, Infectious Disease Vaccines, Cancer Vaccines, Autoimmune Diseases, Others)
8.4 Market Segmentation End User (Hospitals & Clinics, Research & Organizations, Others)
8.5 Europe mRNA Vaccine and Therapeutics Market: Country Analysis
9.Asia Pacific mRNA Vaccine and Therapeutics Market: An Analysis (2021-2030)
9.1 Asia Pacific mRNA Vaccine and Therapeutics Market: Size and Forecast (2021-2030), By Value
9.2 Asia Pacific mRNA Vaccine and Therapeutics Market - Prominent Companies
9.3 Market Segmentation By Product (COVID Vaccines, Infectious Disease Vaccines, Cancer Vaccines, Autoimmune Diseases, Others)
9.4 Market Segmentation End User (Hospitals & Clinics, Research & Organizations, Others )
9.5 Asia Pacific mRNA Vaccine and Therapeutics Market: Country Analysis
10.Global mRNA Vaccine and Therapeutics Market Dynamics
10.1 Drivers
10.2 Restraints
10.3 Trends
11.Market Attractiveness
11.1 Market Attractiveness Chart of Global mRNA Vaccine and Therapeutics Market - By Product, 2030
11.2 Market Attractiveness Chart of Global mRNA Vaccine and Therapeutics Market - By End User, 2030
12. Competitive Landscape
12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers
13.mRNA Vaccine and Therapeutics Pipeline Development
13.1 mRNA vaccine development pipeline for infectious diseases
13.2 mRNA cancer therapies in development
13.3 mRNA-based protein therapeutics in development
14. Regulatory Compliance
15.Company Analysis
Related Report:
Pneumonia Therapeutics Market Size, Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026
The pneumonia therapeutics market will be driven by substantial rise in number of ventilator-associated and community-acquired bacterial pneumonia cases and ongoing clinical trials for the advancement of vaccines and drug molecules. Pneumonia is an infection of the lungs which might infect one or both lungs and fill them up with fluid. It is caused by fungi, viruses, and bacteria. The disease is considered dangerous for adults, infants, those with weakened immune systems, and people suffering from other diseases as well. The treatment of pneumonia usually is dependent upon the germs that cause it.
Bacterial pneumonia is generally treated with antibiotics. The particular antibiotic choice depends on factors like the general health of an individual, the type of medications one is using, any indication of antibiotic resistance in the local community as well the individual’s age, and other health conditions that one might have.
About US:
Market Study Report, LLC. is a hub for market intelligence products and services.
We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.
Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.
If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.